<code id='6C7FC35826'></code><style id='6C7FC35826'></style>
    • <acronym id='6C7FC35826'></acronym>
      <center id='6C7FC35826'><center id='6C7FC35826'><tfoot id='6C7FC35826'></tfoot></center><abbr id='6C7FC35826'><dir id='6C7FC35826'><tfoot id='6C7FC35826'></tfoot><noframes id='6C7FC35826'>

    • <optgroup id='6C7FC35826'><strike id='6C7FC35826'><sup id='6C7FC35826'></sup></strike><code id='6C7FC35826'></code></optgroup>
        1. <b id='6C7FC35826'><label id='6C7FC35826'><select id='6C7FC35826'><dt id='6C7FC35826'><span id='6C7FC35826'></span></dt></select></label></b><u id='6C7FC35826'></u>
          <i id='6C7FC35826'><strike id='6C7FC35826'><tt id='6C7FC35826'><pre id='6C7FC35826'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          Wikipedia

          author:fashion    - browse:85781
          Eli Lilly headquarters
          Kristoffer Tripplaar/AP

          Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

          It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

          advertisement

          At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time